Timely and relevant thoracic oncology news brought to you by the only truly global association dedicated to the multidisciplinary study of lung cancer.

The IASLC Lung Cancer News (ILCN) is the IASLC's official news medium for thoracic oncology specialists around the globe. ILCN provides its international audience with timely and relevant lung cancer news on topics across specialties and interests, such as novel clinical trial design and statistics, overcoming barriers to NGS testing, tobacco control and smoking/vaping cessation, patient-driven research, patient communication and care delivery during COVID, and more. Only the IASLC—the only international association dedicated to the study of lung cancer—can bring you multidisciplinary nuanced perspectives on daily clinical conundrums and the latest novel research by the true experts in the field.


Howard (Jack) West, MD, and Tony Mok, MD
Narjust Duma, MD, Jhanelle E. Gray, MD, and Clarissa Mathias, MD, PhD

North American Conference on Lung Cancer 2020 News

The publication of NACLC 2020

Liquid Biopsy 2020

Liquid Biopsy 2020 News

The publication of Liquid Biopsy 2020

Press releases_2017 opening press conference

For The Media

If you are a member of the media looking for more information about an IASLC-related event or program, please reach out to our media contacts.

IASLC News_landing_Communications Committee box

Communications Committee

Comprising 30 members from around the world and across all areas of lung cancer patient care, including advocacy, the Communications Committee is eager to spotlight IASLC's programs and resources, as well as engage with members about important topics.

Creating Community…
Connect with IASLC and keep up-to-date with our latest news, stories, and insights.


AstraZeneca logo
Amgen logo high res


Daiichi Sankyo Logo
The IASLC and ILCN would like to thank AstraZeneca and Daiichi Sankyo for their support.